Answers are grounded in this paper and cite their sources.
Globally, stroke remains the second-leading cause of death and the third-leading contributor to disability, posing a persistent challenge in medical research. We employed an integrative multi-omics approach combining DNA methylation, gene expression, and protein abundance data. Summary-data-based Mendelian randomization (SMR) with HEIDI testing was used to prioritize molecular traits sharing a causal variant with ischemic stroke (IS). Complementary two-sample Mendelian randomization analyses using the inverse-variance weighted (IVW) method, together with colocalization analysis, were also performed. These analyses were supplemented by animal experiments and single-cell sequencing to systematically explore IS-associated genes and therapeutic targets. The integrative analysis prioritized heme-binding protein 1 (HEBP1) as a candidate risk-associated factor. Western blot and qPCR confirmed elevated HEBP1 expression in middle cerebral artery occlusion (MCAO) rat models. Single-cell analysis localized relatively high HEBP1 expression to oligodendrocytes and showed variation along the inferred differentiation trajectory. Immune-metabolic analysis highlighted HEBP1’s role in rejection, complement activation, and cholesterol homeostasis. The Comparative Toxicogenomics Database (CTD) identified 17 chemicals with curated HEBP1 associations, and exploratory docking yielded a predicted score of −5.55 kcal/mol for phenobarbital. Because this modest in silico score and the CTD annotations do not establish direct binding or inhibition, the chemical findings were considered hypothesis-generating. This study prioritizes HEBP1 as a candidate mechanistic mediator of ischemic stroke through convergent multi-omics, single-cell, and animal-model evidence. Cell-specific perturbation, brain-relevant molecular validation, and direct target-engagement studies are required to determine causal direction, safety, and therapeutic tractability before clinical application can be considered.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: